Viewing SEC Facts Units
Company Name:
Regulus Therapeutics Inc.
CIK:
1505512
Start Filing Date:
2013-01-01
End Filing Date:
2013-03-31
ACCN:
0001193125-13-220102
Value:
$ 35,872,606,000
Value Error:
$ None
Created By:
Date Filed:
2013-05-15
FY:
2013
Fiscal Period:
Q1
Frame:
CY2012Q1
Type:
us-gaap
Form:
10-Q
Units:
shares